Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial

H Houyu Ju Y Yunteng Wu C Chaoji Shi R Ronghui Xia H Hao Song X Xuhui Ma (State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine) Y Yang Liu L Lulu Sun (School of Chemistry) L Ling Zhu L Lingyan Chen S Shuyang Sun Y Yue He G Guoxin Ren J Jingzhou Hu

Article Details

Volume / Issue Vol. 17, Issue 1
Published January 28, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (14)

H

Houyu Ju

Y

Yunteng Wu

C

Chaoji Shi

R

Ronghui Xia

H

Hao Song

X

Xuhui Ma

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine

Y

Yang Liu

L

Lulu Sun

School of Chemistry

L

Ling Zhu

L

Lingyan Chen

S

Shuyang Sun

Y

Yue He

G

Guoxin Ren

J

Jingzhou Hu